DGX
Quest Diagnostics Inc
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Quest Diagnostics Inc
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
No other changes.
No other changes.
Last report5 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Annual filing, covered
10-K parsed · Feb 26 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Feb 26 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
No thesis.
+1.82%
vs ±6.7% implied · ×0.27
shaded = implied · ▲▼ = realized
Quest Diagnostics Inc
247.69
Same SIC code · 6
Same SEC industry code: Labcorp Holdings Inc., Veracyte, Inc., RadNet, Inc. and 3 more; of Quest Diagnostics Inc's 6 closest co-movers, 1 shares that code.
Same SIC code · 6
Same SEC industry code: Labcorp Holdings Inc., Veracyte, Inc., RadNet, Inc. and 3 more; of Quest Diagnostics Inc's 6 closest co-movers, 1 shares that code.
Tall tick = annual report · Source: EDGAR
| Manager | Value | % base | |
|---|---|---|---|
| BlackRockindex-like | $2.0B | 8.84% | +1.12% |
| Vanguardindex-like | $1.5B | 6.89% | +1.23% |
| Vanguard Portfolioindex-like | $1.3B | 5.84% | +0.82% |
| State Streetindex-like | $1.2B | 5.26% | +2.52% |
| T. Rowe Price | $1.2B | 5.19% | −13.54% |
| Manager | Value | % base | |
|---|---|---|---|
| BlackRockindex-like | $2.0B | 8.84% | +1.12% |
| Vanguardindex-like | $1.5B | 6.89% | +1.23% |
| Vanguard Portfolioindex-like | $1.3B | 5.84% | +0.82% |
| State Streetindex-like | $1.2B | 5.26% | +2.52% |
| T. Rowe Price | $1.2B | 5.19% | −13.54% |
Expected move
No implied move.
Bull2
Bear1